Location History:
- Winnersh, GB (2013 - 2016)
- Great Abington, Cambridge, GB (2019)
- Great Abington, GB (2021)
Company Filing History:
Years Active: 2013-2021
Title: The Innovative Contributions of Stephen Roughley
Introduction
Stephen Roughley is a notable inventor based in Winnersh, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his work on fatty acid amide hydrolase (FAAH) inhibitors. With a total of 5 patents to his name, Roughley's innovations are aimed at addressing various medical conditions.
Latest Patents
Among his latest patents, Roughley has developed azetidine derivatives that serve as inhibitors of FAAH. These compounds are particularly useful in treating diseases and medical conditions that benefit from the inhibition of FAAH activity. Such conditions include anxiety, depression, pain, inflammation, and disorders related to eating, sleep, neurodegeneration, and movement. The compounds feature various structural elements, including optionally substituted phenyl and monocyclic heteroaryl groups, which enhance their therapeutic potential.
Career Highlights
Roughley has worked with reputable companies in the pharmaceutical industry, including Vernalis R&D Ltd. and Vernalis Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Some of his notable coworkers include Steven Walls and Terance Hart. Their collaborative efforts have likely played a role in advancing the research and development of innovative pharmaceutical solutions.
Conclusion
Stephen Roughley's work exemplifies the impact of innovation in the field of medicinal chemistry. His contributions through patents and collaborations continue to pave the way for advancements in treating various medical conditions.